Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus
Identifieur interne : 003484 ( Main/Exploration ); précédent : 003483; suivant : 003485Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus
Auteurs : Timothy Sheahan [États-Unis] ; Barry Rockx [États-Unis] ; Eric Donaldson [États-Unis] ; Davide Corti [Suisse] ; Ralph Baric [États-Unis]Source :
- Journal of virology [ 0022-538X ] ; 2008.
Descripteurs français
- KwdFr :
- Analyse de séquence d'ADN, Animaux, Anticorps monoclonaux (immunologie), Cellules Vero, Chine (épidémiologie), Chiroptera (virologie), Cinétique, Données de séquences moléculaires, Effet cytopathogène viral, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (), Glycoprotéines membranaires (génétique), Glycoprotéines membranaires (métabolisme), Gènes viraux, Humains, Liaison aux protéines, Lignée cellulaire, Matrices (génétique), Modèles moléculaires, Mutation ponctuelle, Plasmides, Protéines de l'enveloppe virale (), Protéines de l'enveloppe virale (génétique), Protéines de l'enveloppe virale (métabolisme), Protéines à fluorescence verte (métabolisme), Récepteurs viraux (), Récepteurs viraux (génétique), Récepteurs viraux (métabolisme), Réservoirs d'agents pathogènes, Structure secondaire des protéines, Structure tertiaire des protéines, Syndrome respiratoire aigu sévère (anatomopathologie), Syndrome respiratoire aigu sévère (épidémiologie), Syndrome respiratoire aigu sévère (étiologie), Séquence d'acides aminés, Tests de neutralisation, Transfection, Virus du SRAS (croissance et développement), Virus du SRAS (isolement et purification), Virus du SRAS (pathogénicité), Viverridae (virologie), Zoonoses (transmission), Zoonoses (virologie), Zoonoses (épidémiologie).
- MESH :
- anatomopathologie : Syndrome respiratoire aigu sévère.
- croissance et développement : Virus du SRAS.
- génétique : Glycoprotéines membranaires, Protéines de l'enveloppe virale, Récepteurs viraux.
- immunologie : Anticorps monoclonaux.
- isolement et purification : Virus du SRAS.
- métabolisme : Glycoprotéines membranaires, Protéines de l'enveloppe virale, Protéines à fluorescence verte, Récepteurs viraux.
- pathogénicité : Virus du SRAS.
- virologie : Chiroptera, Viverridae, Zoonoses.
- épidémiologie : Chine, Syndrome respiratoire aigu sévère, Zoonoses.
- étiologie : Syndrome respiratoire aigu sévère.
- Pascal (Inist)
- Analyse de séquence d'ADN, Animaux, Cellules Vero, Cinétique, Coronavirus, Données de séquences moléculaires, Effet cytopathogène viral, Espèce, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires, Gènes viraux, Humains, Liaison aux protéines, Lignée cellulaire, Matrices (génétique), Modèles moléculaires, Mutation ponctuelle, Plasmides, Protéines de l'enveloppe virale, Récepteurs viraux, Réservoirs d'agents pathogènes, Structure secondaire des protéines, Structure tertiaire des protéines, Séquence d'acides aminés, Tests de neutralisation, Transfection, Transmission, Virologie, Syndrome respiratoire aigu sévère.
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Amino Acid Sequence, Animals, Antibodies, Monoclonal (immunology), Cell Line, China (epidemiology), Chiroptera (virology), Chlorocebus aethiops, Coronavirus, Cytopathogenic Effect, Viral, Disease Reservoirs, Genes, Viral, Green Fluorescent Proteins (metabolism), Humans, Kinetics, Membrane Glycoproteins (chemistry), Membrane Glycoproteins (genetics), Membrane Glycoproteins (metabolism), Models, Molecular, Molecular Sequence Data, Neutralization Tests, Plasmids, Point Mutation, Protein Binding, Protein Structure, Secondary, Protein Structure, Tertiary, Receptors, Virus (chemistry), Receptors, Virus (genetics), Receptors, Virus (metabolism), SARS Virus (growth & development), SARS Virus (isolation & purification), SARS Virus (pathogenicity), Sequence Analysis, DNA, Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (etiology), Severe Acute Respiratory Syndrome (pathology), Severe acute respiratory syndrome, Species, Spike Glycoprotein, Coronavirus, Templates, Genetic, Transfection, Transmission, Vero Cells, Viral Envelope Proteins (chemistry), Viral Envelope Proteins (genetics), Viral Envelope Proteins (metabolism), Virology, Viverridae (virology), Zoonoses (epidemiology), Zoonoses (transmission), Zoonoses (virology).
- MESH :
- chemical , chemistry : Membrane Glycoproteins, Receptors, Virus, Viral Envelope Proteins.
- chemical , genetics : Membrane Glycoproteins, Receptors, Virus, Viral Envelope Proteins.
- chemical , immunology : Antibodies, Monoclonal.
- geographic , epidemiology : China.
- chemical , metabolism : Green Fluorescent Proteins, Membrane Glycoproteins, Receptors, Virus, Viral Envelope Proteins.
- epidemiology : Severe Acute Respiratory Syndrome, Zoonoses.
- etiology : Severe Acute Respiratory Syndrome.
- growth & development : SARS Virus.
- isolation & purification : SARS Virus.
- pathogenicity : SARS Virus.
- pathology : Severe Acute Respiratory Syndrome.
- transmission : Zoonoses.
- virology : Chiroptera, Viverridae, Zoonoses.
- Amino Acid Sequence, Animals, Cell Line, Chlorocebus aethiops, Cytopathogenic Effect, Viral, Disease Reservoirs, Genes, Viral, Humans, Kinetics, Models, Molecular, Molecular Sequence Data, Neutralization Tests, Plasmids, Point Mutation, Protein Binding, Protein Structure, Secondary, Protein Structure, Tertiary, Sequence Analysis, DNA, Spike Glycoprotein, Coronavirus, Templates, Genetic, Transfection, Vero Cells.
Abstract
Zoonotic severe acute respiratory syndrome coronavirus (SARS-CoV) likely evolved to infect humans by a series of transmission events between humans and animals in markets in China. Virus sequence data suggest that the palm civet served as an amplification host in which civet and human interaction fostered the evolution of the epidemic SARS Urbani strain. The prototypic civet strain of SARS-CoV, SZ16, was isolated from a palm civet but has not been successfully cultured in vitro. To propagate a chimeric recombinant SARS-CoV bearing an SZ16 spike (S) glycoprotein (icSZ16-S), we constructed cell lines expressing the civet ortholog (DBT-cACE2) of the SARS-CoV receptor (hACE2). Zoonotic SARS-CoV was completely dependent on ACE2 for entry. Urbani grew with similar kinetics in both the DBT-cACE2 and the DBT-hACE2 cells, while icSZ16-S only grew in DBT-cACE2 cells. The SZ16-S mutant viruses adapted to human airway epithelial cells and displayed enhanced affinity for hACE2 but exhibited severe growth defects in the DBT-cACE2 cells, suggesting that the evolutionary pathway that promoted efficient hACE2 interactions simultaneously abolished efficient cACE2 interactions. Structural modeling predicted two distinct biochemical interaction networks by which zoonotic receptor binding domain architecture can productively engage hACE2, but only the Urbani mutational repertoire promoted efficient usage of both hACE2 and cACE2 binding interfaces. Since dual species tropism was preserved in Urbani, it is likely that the virus evolved a high affinity for cACE2/hACE2 receptors through adaptation via repeated passages between human and civet hosts. Furthermore, zoonotic SARS-CoV was variably neutralized by antibodies that were effective against the epidemic strain, highlighting their utility for evaluating passive immunization efficacy.
Url:
Affiliations:
- Suisse, États-Unis
- Caroline du Nord
- Chapel Hill (Caroline du Nord)
- Université de Caroline du Nord à Chapel Hill
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000257
- to stream PascalFrancis, to step Curation: 000731
- to stream PascalFrancis, to step Checkpoint: 000264
- to stream Main, to step Merge: 003590
- to stream Pmc, to step Corpus: 000666
- to stream Pmc, to step Curation: 000666
- to stream Pmc, to step Checkpoint: 000D96
- to stream PubMed, to step Corpus: 001B15
- to stream PubMed, to step Curation: 001B15
- to stream PubMed, to step Checkpoint: 001A72
- to stream Ncbi, to step Merge: 001C85
- to stream Ncbi, to step Curation: 001C85
- to stream Ncbi, to step Checkpoint: 001C85
- to stream Main, to step Merge: 003138
- to stream Main, to step Curation: 003484
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus</title><author><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Rockx, Barry" sort="Rockx, Barry" uniqKey="Rockx B" first="Barry" last="Rockx">Barry Rockx</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Epidemiology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Donaldson, Eric" sort="Donaldson, Eric" uniqKey="Donaldson E" first="Eric" last="Donaldson">Eric Donaldson</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Corti, Davide" sort="Corti, Davide" uniqKey="Corti D" first="Davide" last="Corti">Davide Corti</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institute for Research in Biomedicine</s1><s2>Bellinzona</s2><s3>CHE</s3><sZ>4 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>Institute for Research in Biomedicine</wicri:noRegion></affiliation></author><author><name sortKey="Baric, Ralph" sort="Baric, Ralph" uniqKey="Baric R" first="Ralph" last="Baric">Ralph Baric</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Epidemiology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">08-0411857</idno><date when="2008">2008</date><idno type="stanalyst">PASCAL 08-0411857 INIST</idno><idno type="RBID">Pascal:08-0411857</idno><idno type="wicri:Area/PascalFrancis/Corpus">000257</idno><idno type="wicri:Area/PascalFrancis/Curation">000731</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000264</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000264</idno><idno type="wicri:doubleKey">0022-538X:2008:Sheahan T:pathways:of:cross</idno><idno type="wicri:Area/Main/Merge">003590</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519660</idno><idno type="RBID">PMC:2519660</idno><idno type="wicri:Area/Pmc/Corpus">000666</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000666</idno><idno type="wicri:Area/Pmc/Curation">000666</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000666</idno><idno type="wicri:Area/Pmc/Checkpoint">000D96</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000D96</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:18579604</idno><idno type="wicri:Area/PubMed/Corpus">001B15</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B15</idno><idno type="wicri:Area/PubMed/Curation">001B15</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B15</idno><idno type="wicri:Area/PubMed/Checkpoint">001A72</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A72</idno><idno type="wicri:Area/Ncbi/Merge">001C85</idno><idno type="wicri:Area/Ncbi/Curation">001C85</idno><idno type="wicri:Area/Ncbi/Checkpoint">001C85</idno><idno type="wicri:doubleKey">0022-538X:2008:Sheahan T:pathways:of:cross</idno><idno type="wicri:Area/Main/Merge">003138</idno><idno type="wicri:Area/Main/Curation">003484</idno><idno type="wicri:Area/Main/Exploration">003484</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus</title><author><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Rockx, Barry" sort="Rockx, Barry" uniqKey="Rockx B" first="Barry" last="Rockx">Barry Rockx</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Epidemiology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Donaldson, Eric" sort="Donaldson, Eric" uniqKey="Donaldson E" first="Eric" last="Donaldson">Eric Donaldson</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Corti, Davide" sort="Corti, Davide" uniqKey="Corti D" first="Davide" last="Corti">Davide Corti</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Institute for Research in Biomedicine</s1><s2>Bellinzona</s2><s3>CHE</s3><sZ>4 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>Institute for Research in Biomedicine</wicri:noRegion></affiliation></author><author><name sortKey="Baric, Ralph" sort="Baric, Ralph" uniqKey="Baric R" first="Ralph" last="Baric">Ralph Baric</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Epidemiology, University of North Carolina at Chapel Hill</s1><s2>Chapel Hill, North Carolina</s2><s3>USA</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author></analytic><series><title level="j" type="main">Journal of virology</title><title level="j" type="abbreviated">J. virol.</title><idno type="ISSN">0022-538X</idno><imprint><date when="2008">2008</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of virology</title><title level="j" type="abbreviated">J. virol.</title><idno type="ISSN">0022-538X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Antibodies, Monoclonal (immunology)</term><term>Cell Line</term><term>China (epidemiology)</term><term>Chiroptera (virology)</term><term>Chlorocebus aethiops</term><term>Coronavirus</term><term>Cytopathogenic Effect, Viral</term><term>Disease Reservoirs</term><term>Genes, Viral</term><term>Green Fluorescent Proteins (metabolism)</term><term>Humans</term><term>Kinetics</term><term>Membrane Glycoproteins (chemistry)</term><term>Membrane Glycoproteins (genetics)</term><term>Membrane Glycoproteins (metabolism)</term><term>Models, Molecular</term><term>Molecular Sequence Data</term><term>Neutralization Tests</term><term>Plasmids</term><term>Point Mutation</term><term>Protein Binding</term><term>Protein Structure, Secondary</term><term>Protein Structure, Tertiary</term><term>Receptors, Virus (chemistry)</term><term>Receptors, Virus (genetics)</term><term>Receptors, Virus (metabolism)</term><term>SARS Virus (growth & development)</term><term>SARS Virus (isolation & purification)</term><term>SARS Virus (pathogenicity)</term><term>Sequence Analysis, DNA</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (etiology)</term><term>Severe Acute Respiratory Syndrome (pathology)</term><term>Severe acute respiratory syndrome</term><term>Species</term><term>Spike Glycoprotein, Coronavirus</term><term>Templates, Genetic</term><term>Transfection</term><term>Transmission</term><term>Vero Cells</term><term>Viral Envelope Proteins (chemistry)</term><term>Viral Envelope Proteins (genetics)</term><term>Viral Envelope Proteins (metabolism)</term><term>Virology</term><term>Viverridae (virology)</term><term>Zoonoses (epidemiology)</term><term>Zoonoses (transmission)</term><term>Zoonoses (virology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de séquence d'ADN</term><term>Animaux</term><term>Anticorps monoclonaux (immunologie)</term><term>Cellules Vero</term><term>Chine (épidémiologie)</term><term>Chiroptera (virologie)</term><term>Cinétique</term><term>Données de séquences moléculaires</term><term>Effet cytopathogène viral</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires ()</term><term>Glycoprotéines membranaires (génétique)</term><term>Glycoprotéines membranaires (métabolisme)</term><term>Gènes viraux</term><term>Humains</term><term>Liaison aux protéines</term><term>Lignée cellulaire</term><term>Matrices (génétique)</term><term>Modèles moléculaires</term><term>Mutation ponctuelle</term><term>Plasmides</term><term>Protéines de l'enveloppe virale ()</term><term>Protéines de l'enveloppe virale (génétique)</term><term>Protéines de l'enveloppe virale (métabolisme)</term><term>Protéines à fluorescence verte (métabolisme)</term><term>Récepteurs viraux ()</term><term>Récepteurs viraux (génétique)</term><term>Récepteurs viraux (métabolisme)</term><term>Réservoirs d'agents pathogènes</term><term>Structure secondaire des protéines</term><term>Structure tertiaire des protéines</term><term>Syndrome respiratoire aigu sévère (anatomopathologie)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Syndrome respiratoire aigu sévère (étiologie)</term><term>Séquence d'acides aminés</term><term>Tests de neutralisation</term><term>Transfection</term><term>Virus du SRAS (croissance et développement)</term><term>Virus du SRAS (isolement et purification)</term><term>Virus du SRAS (pathogénicité)</term><term>Viverridae (virologie)</term><term>Zoonoses (transmission)</term><term>Zoonoses (virologie)</term><term>Zoonoses (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Membrane Glycoproteins</term><term>Receptors, Virus</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Glycoproteins</term><term>Receptors, Virus</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Monoclonal</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>China</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Green Fluorescent Proteins</term><term>Membrane Glycoproteins</term><term>Receptors, Virus</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Glycoprotéines membranaires</term><term>Protéines de l'enveloppe virale</term><term>Récepteurs viraux</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps monoclonaux</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycoprotéines membranaires</term><term>Protéines de l'enveloppe virale</term><term>Protéines à fluorescence verte</term><term>Récepteurs viraux</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Chiroptera</term><term>Viverridae</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Chiroptera</term><term>Viverridae</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Chine</term><term>Syndrome respiratoire aigu sévère</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Cell Line</term><term>Chlorocebus aethiops</term><term>Cytopathogenic Effect, Viral</term><term>Disease Reservoirs</term><term>Genes, Viral</term><term>Humans</term><term>Kinetics</term><term>Models, Molecular</term><term>Molecular Sequence Data</term><term>Neutralization Tests</term><term>Plasmids</term><term>Point Mutation</term><term>Protein Binding</term><term>Protein Structure, Secondary</term><term>Protein Structure, Tertiary</term><term>Sequence Analysis, DNA</term><term>Spike Glycoprotein, Coronavirus</term><term>Templates, Genetic</term><term>Transfection</term><term>Vero Cells</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Analyse de séquence d'ADN</term><term>Animaux</term><term>Cellules Vero</term><term>Cinétique</term><term>Coronavirus</term><term>Données de séquences moléculaires</term><term>Effet cytopathogène viral</term><term>Espèce</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires</term><term>Gènes viraux</term><term>Humains</term><term>Liaison aux protéines</term><term>Lignée cellulaire</term><term>Matrices (génétique)</term><term>Modèles moléculaires</term><term>Mutation ponctuelle</term><term>Plasmides</term><term>Protéines de l'enveloppe virale</term><term>Récepteurs viraux</term><term>Réservoirs d'agents pathogènes</term><term>Structure secondaire des protéines</term><term>Structure tertiaire des protéines</term><term>Séquence d'acides aminés</term><term>Tests de neutralisation</term><term>Transfection</term><term>Transmission</term><term>Virologie</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Zoonotic severe acute respiratory syndrome coronavirus (SARS-CoV) likely evolved to infect humans by a series of transmission events between humans and animals in markets in China. Virus sequence data suggest that the palm civet served as an amplification host in which civet and human interaction fostered the evolution of the epidemic SARS Urbani strain. The prototypic civet strain of SARS-CoV, SZ16, was isolated from a palm civet but has not been successfully cultured in vitro. To propagate a chimeric recombinant SARS-CoV bearing an SZ16 spike (S) glycoprotein (icSZ16-S), we constructed cell lines expressing the civet ortholog (DBT-cACE2) of the SARS-CoV receptor (hACE2). Zoonotic SARS-CoV was completely dependent on ACE2 for entry. Urbani grew with similar kinetics in both the DBT-cACE2 and the DBT-hACE2 cells, while icSZ16-S only grew in DBT-cACE2 cells. The SZ16-S mutant viruses adapted to human airway epithelial cells and displayed enhanced affinity for hACE2 but exhibited severe growth defects in the DBT-cACE2 cells, suggesting that the evolutionary pathway that promoted efficient hACE2 interactions simultaneously abolished efficient cACE2 interactions. Structural modeling predicted two distinct biochemical interaction networks by which zoonotic receptor binding domain architecture can productively engage hACE2, but only the Urbani mutational repertoire promoted efficient usage of both hACE2 and cACE2 binding interfaces. Since dual species tropism was preserved in Urbani, it is likely that the virus evolved a high affinity for cACE2/hACE2 receptors through adaptation via repeated passages between human and civet hosts. Furthermore, zoonotic SARS-CoV was variably neutralized by antibodies that were effective against the epidemic strain, highlighting their utility for evaluating passive immunization efficacy.</div></front></TEI><affiliations><list><country><li>Suisse</li><li>États-Unis</li></country><region><li>Caroline du Nord</li></region><settlement><li>Chapel Hill (Caroline du Nord)</li></settlement><orgName><li>Université de Caroline du Nord à Chapel Hill</li></orgName></list><tree><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name></region><name sortKey="Baric, Ralph" sort="Baric, Ralph" uniqKey="Baric R" first="Ralph" last="Baric">Ralph Baric</name><name sortKey="Baric, Ralph" sort="Baric, Ralph" uniqKey="Baric R" first="Ralph" last="Baric">Ralph Baric</name><name sortKey="Donaldson, Eric" sort="Donaldson, Eric" uniqKey="Donaldson E" first="Eric" last="Donaldson">Eric Donaldson</name><name sortKey="Rockx, Barry" sort="Rockx, Barry" uniqKey="Rockx B" first="Barry" last="Rockx">Barry Rockx</name></country><country name="Suisse"><noRegion><name sortKey="Corti, Davide" sort="Corti, Davide" uniqKey="Corti D" first="Davide" last="Corti">Davide Corti</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003484 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003484 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:08-0411857
|texte= Pathways of Cross-Species Transmission of Synthetically Reconstructed Zoonotic Severe Acute Respiratory Syndrome Coronavirus
}}
| This area was generated with Dilib version V0.6.33. |  |